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Polyglutamylation is a posttranslational modification
that generates glutamate side chains on tubulins
and other proteins. Although this modification has
been shown to be reversible, little is known about
the enzymes catalyzing deglutamylation. Here we
describe the enzymatic mechanism of protein deglu-
tamylation bymembers of the cytosolic carboxypep-
tidase (CCP) family. Three enzymes (CCP1, CCP4,
and CCP6) catalyze the shortening of polyglutamate
chains and a fourth (CCP5) specifically removes
the branching point glutamates. In addition, CCP1,
CCP4, and CCP6 also remove gene-encoded gluta-
mates from the carboxyl termini of proteins. Accord-
ingly, we show that these enzymes convert detyrosi-
nated tubulin into D2-tubulin and also modify other
substrates, including myosin light chain kinase 1.
We further analyze Purkinje cell degeneration (pcd)
mice that lack functional CCP1 and show that micro-
tubule hyperglutamylation is directly linked to neuro-
degeneration. Taken together, our results reveal that
controlling the length of the polyglutamate side
chains on tubulin is critical for neuronal survival.
INTRODUCTION
Polyglutamylation is a posttranslational modification that gener-
ates glutamate side chains of variable length on the g-carboxyl
groups of glutamic acid residues within the primary sequence
of the target proteins. This modification has been initially discov-
ered on a- and b-tubulin, the building blocks of microtubules
(MTs; Edde´ et al., 1990; Ru¨diger et al., 1992), and later also found
on other proteins (Regnard et al., 2000; van Dijk et al., 2008).
Polyglutamylation levels are particularly high on stable MT
assemblies such as the ones found in neurons (Audebert et al.,564 Cell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc.1993), axonemes (Bre´ et al., 1994), centrioles, and basal bodies
(Bobinnec et al., 1998) but is also enriched in the highly dynamic
mitotic spindle (Regnard et al., 1999). Tubulins are polyglutamy-
lated at their carboxy-terminal tails, which upon assembly of
MTs become exposed on the outer surface of the tubules,
where they provide binding sites for several MT-associated
proteins (MAPs) andmolecular motors. Accordingly, MT polyglu-
tamylation has recently been shown to regulate the activity of
ciliary dynein (Kubo et al., 2010; Suryavanshi et al., 2010) and
of the MT-severing protein spastin (Lacroix et al., 2010).
The enzymes that catalyze polyglutamylation, polyglutamy-
lases, are members of a protein family sharing a homology
domain with another tubulin-modifying enzyme, tubulin tyrosine
ligase (TTL; Ersfeld et al., 1993), and thus are referred to as
TTL-like (TTLL) proteins (Janke et al., 2005; van Dijk et al.,
2007). Initial functional studies on polyglutamylases provided
first evidence that polyglutamylation plays important roles
in vivo. Mice knocked out for TTLL1 polyglutamylase display
abnormal beating of airway epithelial cilia leading to respiratory
problems (Ikegami et al., 2010). Another polyglutamylase,
TTLL6, was also shown to play a role in cilia. Depletion of this
enzyme in zebrafish reduced glutamylation in the olfactory plac-
odes resulting in defective assembly of olfactory cilia (Pathak
et al., 2007). Surprisingly, also overexpression of TTLL6 enzyme,
which caused abnormal elongation of glutamate chains,
produced ciliary defects in Tetrahymena (Janke et al., 2005;
Wloga et al., 2009). Taken together, this suggests that maintain-
ing the correct levels of tubulin polyglutamylation by the coordi-
nated action of polyglutamylases and deglutamylating enzymes
is essential. The aim of the present work was to identify degluta-
mylating enzymes and analyze their functions in vivo.
Recent studies of a family of cytosolic carboxypeptidases
(CCPs) have suggested that one of the members of this family,
CCP1 (also known as Nna1), is the enzyme that removes the
C-terminal tyrosine from a-tubulin (Kalinina et al., 2007; Rodri-
guez de la Vega et al., 2007); however convincing evidence
has not been provided. The possibility that CCP1 is involved in
tubulin modifications was exciting because loss of function of
CCP1 had been associated with the phenotypes observed in
Purkinje cell degeneration (pcd) mice (Fernandez-Gonzalez
et al., 2002). pcdmice display multiple defects including degen-
eration of several types of neurons. The first neurons to be lost
are Purkinje cells, which die during early adulthood leading to
ataxia. The loss of Purkinje cells is followed by degeneration of
cerebellar granule neurons (CGNs), and later some populations
of thalamic neurons also disappear (Mullen et al., 1976). More-
over, mitral cells from the olfactory bulb as well as retinal
photoreceptors degenerate progressively over 1 year. Finally,
the males are sterile and the females experience difficulties
giving birth (reviewed in Wang and Morgan, 2007). Recent
studies demonstrated that Purkinje cell loss as well as retinal
degeneration observed in the pcd mice could be rescued by
wild-type (WT) CCP1 but not an inactive CCP1 (Chakrabarti
et al., 2008; Wang et al., 2006). This demonstrated that the
lack of CCP1 carboxypeptidase activity is responsible for the
phenotypes observed in the pcd mice; however, the molecular
mechanisms underlying the numerous defects remain unclear.
Here, we show that CCP1 specifically catalyzes the removal of
the penultimate glutamate residue from detyrosinated a-tubulin,
thus generating D2-tubulin; however, it is not involved in detyro-
sination itself. Moreover, we demonstrate that the removal of
gene-encoded glutamic acids from the C termini of proteins is
not specific to tubulin but affects a range of substrates including
myosin light chain kinase 1 (MLCK1). Apart from the deglutamy-
lation of protein primary sequence, CCP1 also shortens post-
translationally generated glutamate side chains on tubulin and
is therefore a tubulin deglutamylase. We further demonstrate
the existence of two functional homologs of CCP1, CCP4, and
CCP6, and we provide evidence that another recently described
deglutamylating enzyme, CCP5 (Kimura et al., 2010), specifically
removes the branching point glutamates generated by polyglu-
tamylation. Finally, we have analyzed the neurodegeneration
phenotype in the pcd mice in light of the newly identified deglu-
tamylating activity of CCP1. Consistent with the enzymatic
activity of CCP1, we show that tubulin polyglutamylation is highly
increased specifically in brain areas that degenerate in the pcd
mice. Moreover, by downregulating polyglutamylation, we
were able to partially prevent neurodegeneration, providing
direct evidence that abnormally high polyglutamylation levels
lead to neuronal degeneration.
RESULTS
CCP1 Generates D2-Tubulin and Also Acts as a Tubulin
Deglutamylase
Recent studies have suggested that CCP1 is involved in
a-tubulin detyrosination (Kalinina et al., 2007). To directly test
this idea, we performed immunoblot analysis of protein extracts
prepared from HEK293 cells expressing either active or enzy-
matically inactive (dead, Figure S1 available online) murine
CCP1. Although we did not observe any increase in the level of
tubulin detyrosination, we detected an ectopic appearance of
a related tubulin modification, D2-tubulin (Paturle-Lafanechere
et al., 1991). Thus, CCP1 seems to catalyze the removal of the
penultimate glutamate residue, but not detyrosination itself. To
further test whether CCP1 is specifically generating D2-tubulin,we expressed this protein in mouse embryonic fibroblasts
(MEFs) and stained the cells with antibodies for tyrosinated
and D2-tubulin. There was no obvious reduction in the level of
tyrosinated tubulin, but we observed a strong increase in the
labeling for D2-tubulin specifically in cells expressing CCP1 (Fig-
ure 1B). This increase in the level of D2-tubulin was not observed
when the enzymatically dead version of CCP1 was expressed
(Figure S2A). Taken together these results demonstrate that
CCP1 catalyzes the removal of the very C-terminal glutamate
residue from detyrosinated a-tubulin, but it is not involved in
a-tubulin detyrosination.
Considering that CCP1 was associated with a-tubulin primary
sequence deglutamylation, we speculated that it might also
catalyze the removal of glutamate side chains, which are added
to a- and b-tubulin as a result of posttranslational polyglutamyla-
tion (Edde´ et al., 1990; Ru¨diger et al., 1992). To test this hypoth-
esis, we expressed CCP1 in neurons, which are known to carry
a high level of tubulin polyglutamylation (Audebert et al., 1993),
and labeled them with polyE antibody that recognizes glutamate
chains composed of at least three glutamic acids (Figure S3).
Neurons expressing active but not inactive CCP1 showed
a strong reduction in the level of polyE signal (Figure 1C and Fig-
ure S2B). These results show that CCP1 is indeed involved in the
removal of posttranslational polyglutamylation.
To further characterize the deglutamylation activity of CCP1,
we set up an in vitro deglutamylation assay in which highly
polyglutamylated brain tubulin was incubated with protein
extract from HEK293 cells expressing either active or inactive
CCP1. The status of polyglutamylation was examined with two
polyglutamylation-specific antibodies: polyE that recognizes
long glutamate side chains, and GT335 that recognizes all gluta-
mylated forms of tubulin because it is specific to the branching
point of the glutamate side chain (Wolff et al., 1992). In combina-
tion, these two antibodies allowed us to distinguish between
tubulin carrying either short or long glutamate side chains. Brain
tubulin treated with active CCP1 was no longer detected by
polyE antibodies, while the GT335 signal was not decreased
(Figure 1D). This indicated that CCP1 shortens the glutamate
side chains of brain tubulin without removing the branching point
glutamates. Similar results were obtained with purified
6His-CCP1, confirming that CCP1 directly catalyzes tubulin de-
glutamylation (Figures S2C and S2D). To further investigate the
enzymatic specificity of CCP1 for long side chains, we assayed
the enzyme with mono- or polyglutamylated tubulin purified
from HeLa cells after overexpression of different TTLL glutamy-
lating enzymes (van Dijk et al., 2007). When monoglutamylated
tubulin (modified by TTLL4) was incubated with active CCP1,
no changes in glutamylation levels were observed, indicating
that CCP1 cannot remove the short side chains generated by
TTLL4 (Figure 1D). Surprisingly, when tubulin polyglutamylated
with TTLL6 was incubated with CCP1, a strong reduction in
both polyE and GT335 signals was observed (Figure 1D). This
indicated that besides shortening the polyglutamate side chains,
CCP1 also removes the branching point glutamates when the
glutamylation is generated by TTLL6 but not by TTLL4 or by
TTLL1, which generates most of the glutamylation present on
brain MTs (Janke et al., 2005). To validate that the removal of
the branching point glutamates by CCP1 depends on theCell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc. 565
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enzyme that has generated glutamylation in the first place, we
set up cotransfection experiments. CCP1 was coexpressed
together with TTLL4 or TTLL6 in HEK293 cells, and the cell
extracts were analyzed by immunoblot. In agreement with our
in vitro data, expression of CCP1 had no effect on the glutamy-
lation status of tubulin and other proteins that are modified
by TTLL4. In contrast, CCP1 blocked the accumulation of
both mono- and polyglutamylation on TTLL6 substrates, which
include tubulins and TTLL6 itself (Figure 1E). These results
confirmed that CCP1, in addition to shortening long glutamate
chains, also removes the branching point glutamates when the
modification is generated by TTLL6 but not TTLL4.
Tubulin Modifications in the pcd Mouse that Lacks
Active CCP1
To study the role of CCP1 in vivo, we took advantage of Purkinje
cell degeneration (pcd3J) mice in which a deletion in the CCP1
gene results in loss of function of the CCP1 protein (Fernandez-
Gonzalez et al., 2002). Based on our discovery of the
deglutamylating activity of CCP1 we expected the absence of
D2-tubulin and increased tubulin polyglutamylation in the pcd
mice. To test our predictions we compared the status of tubulin
modifications between pcd and WT mice. Protein extracts from
several organs were analyzed by immunoblot with antibodies
recognizing either the unmodifiedC-terminal a-tubulin tail (tyrosi-
nated tubulin) or its processed versions (detyrosinated or
D2-tubulin), as well as with polyE antibodies specific to long
glutamate chains. When comparing the levels of tyrosinated
and detyrosinated tubulin between pcd and WT mice, we
observed no differences in all organs analyzed. Surprisingly,
the D2-tubulin modification was also unchanged in most of the
organs except skeletal muscles, where we detected a strong
reduction (Figure 2A). This confirmed that CCP1 is involved in
generating D2-tubulin in vivo, but at the same time it implied the
existence of additional enzyme(s) catalyzing this modification.
Tubulin polyglutamylation, for which we expected an increase
in the pcdmice, at least in the organswhere tubulin glutamylases
are highly expressed such as brain and testes, was indeed
slightly increased relative to the equal levels of tyrosinated tubulin
in these two organs (Figure 2A). These results are in agreement
with CCP1 being involved in the removal of posttranslational
tubulin polyglutamylation.
In contrast tomostly slight changes in the levels of tubulin post-
translational modifications observed in the pcd mice, we
detected protein bands outside of the tubulin region that reacted
with anti-D2-tubulin exclusively in the WT mice. Conversely,
bands of corresponding size were labeled by detyrosinated or
polyE antibodies in the pcd mice (Figure 2A). This suggested
the existence of proteins that end with a -GEn sequence at theirFigure 1. Enzymatic Characterization of CCP1
(A) Immunoblot of protein extracts from HEK293 cells expressing active (EYFP-C
(B) Immunofluorescenceofmouseembryonicfibroblasts (MEFs) expressingEGFP-C
(C) Immunofluorescence of mouse hippocampal neurons expressing EGFP-CCP1.
(D) Immunoblot of tubulin treated with extracts fromHEK293 cell expressing either a
HeLa tubulin modified with either TTLL4 or TTLL6. TTLL4 does not generate a poly
(E) Immunoblot of protein extracts prepared fromHEK293 cells coexpressing TTLL4
GT335 signal generated by TTLL4 is not removed by CCP1, whereas TTLL6-depen
Scale bars in (B) and (C) are 20 mm. See also Figure S1 and Figure S2.C termini, which is recognized in the pcd mice with polyE (if
nR 3) or with detyrosinated antibody (if n = 2). However, in WT
mice, both types of proteins have C termini shortened to -GE
(specifically detected with anti-D2-tubulin antibody), most likely
by the enzymatic activity of CCP1. Thus, C-terminal deglutamy-
lation seems to be a modification that is not restricted to tubulin.
MLCK1 and Telokin Are Substrates of CCP1
Two of the potential CCP1 substrates (130 kDa and 20 kDa)
were prominent in stomach and one (130 kDa) in the uterus
(Figure 2A). In order to identify these substrates, we prepared
protein extract from mouse stomach and analyzed the two
anti-D2-reactive bands by mass spectrometry. Several proteins
were identified (Table S2 and Table S3), but only two appeared
as promising candidates for being processed by CCP1. Myosin
light chain kinase 1 (130 kDa MLCK1) and telokin, a 17 kDa
protein corresponding to the C-terminal fragment of MLCK1
(Smith et al., 1998), endwith the sequence -EGEEGGEEEEEEEE.
Thus, both proteins could be detected with polyE, or when pro-
cessed byCCP1 to -EGEEGGEwith anti-D2-tubulin antibody. To
provide additional evidence that MLCK1 undergoes C-terminal
deglutamylation, we used an anti-MLCK antibody for immuno-
precipitation from stomach and uterus extracts and showed
that the immunoprecipitated protein was detected by anti-D2-
tubulin antibodies (Figure 2B). To demonstrate that MLCK and
telokin are processed by CCP1, we expressed them together
with active or inactive CCP1 in HEK293 cells and analyzed the
protein extracts by immunoblot (see Figure S3 for antibody
specificities). In the presence of inactive CCP1, both MLCK1
and telokin were recognized by polyE but not anti-D2-tubulin
antibodies. In contrast, when MLCK1 and telokin were ex-
pressed together with active CCP1, both proteins were labeled
by anti-D2-tubulin but not polyE antibodies (Figure 2C). To
confirm that CCP1 directly catalyzes primary sequence degluta-
mylation, we incubated purified GST-telokin with purified
6His-CCP1. GST-telokin treated with CCP1 was recognized by
anti-D2-tubulin but not polyE antibodies, demonstrating that
CCP1 shortened the C-terminal glutamate stretch (Figure 2D).
Primary sequence deglutamylation was no longer observed in
the presence of phenanthroline, a specific inhibitor of metallo-
proteases (Figure 2D). These results clearly show that MLCK1
and telokin are directly processed by CCP1 in the way that seven
out of eight C-terminal glutamates are removed from the C
termini of these proteins.
Finally, we tested whether CCP1 activity is restricted to the
removal of glutamates, or if this enzyme could potentially also
process other amino acids. Based on telokin, we generated
several artificial substrates ending with the C-terminal
sequences -GED, -GEEDD, -GEEY, and -GEEF. All of theseCP1) or inactive (EYFP-CCP1d) CCP1.
CP1.Anti-D2-tubulin antibodyspecifically labels thecell expressingEGFP-CCP1.
PolyE antibody does not label the cell expressing EGFP-CCP1.
ctive or inactive EYFP-CCP1. Three types of tubulin were used: brain tubulin and
E signal on tubulin (not shown).
-EYFP or TTLL6-EYFP together with active or inactive EYFP-CCP1. Note that the
dent GT335 labeling on tubulin and TTLL6 is reduced by CCP1.
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Figure 2. Characterization of CCP1 Substrates
(A) Comparative immunoblot of protein extracts prepared from organs of WT and pcdmice.Whole-tissue extracts were tested with anti-tyr-tubulin, detyr-tubulin,
D2-tubulin, and polyE. Note the disappearance of anti-D2-tubulin and anti-detyr-tubulin labeling and increase in polyE staining for 130 kDa substrate in the
extracts from stomach and uterus of the pcd mice.
(B) Immunoprecipitations with anti-MLCK1 antibodies using protein extracts from stomach and uterus ofWTmice. The fractionswere tested in immunoblot. In the
bound fraction, protein bands of the same size are detected with anti-D2-tubulin and anti-MLCK1 antibodies. (*degradation product.)
(C) Immunoblot of protein extracts prepared from HEK293 cells coexpressing EYFP-CCP1 or EYFP-CCP1d together with EYFP-MLCK1 or EYFP-telokin. The
D2-tubulin labeling correlates with the expression of active CCP1, and polyE labeling correlates with the expression of inactive CCP1.
(D) In vitro deglutamylation assay with purified GST-telokin and 6His-CCP1. GST-telokin and 6His-CCP1 were incubated in the presence or absence of phenan-
throline. GST-telokin is specifically detected with D2-tubulin antibody after incubation with 6His-CCP1. In the presence of phenanthroline, telokin remains in the
polyE-reactive form and is not detected by anti-D2-tubulin antibody.
(E) Immunoblot of protein extract from HEK293 cells coexpressing EYFP-CCP1 and different artificial substrates based on EYFP-telokin. The sequence of the
C-terminal tails of the telokin-like substrates is indicated starting from glycine 151. Only WT telokin (-GEEEEEEEE) coexpressed with CCP1 is labeled by
anti-D2-tubulin antibody.
See also Figure S3, Table S1, Table S2, Table S3, and Table S4.artificial telokins including WT telokin were cotransfected with
CCP1 in HEK293 cells, and the protein extracts were analyzed
with anti-D2-tubulin antibodies on immunoblot. Only WT telokin
was detected with anti-D2-tubulin antibody (Figure 2E), indi-
cating that CCP1 is a highly specific carboxypeptidase that
exclusively cuts peptide bonds between two C-terminally568 Cell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc.located glutamates. Even aspartate, the amino acid that most
closely resembles glutamate, was not removed by CCP1. In
addition, aromatic residues such as tyrosine and phenylalanine
were also blocking deglutamylation of telokin, which is coherent
with our data indicating that CCP1 does not catalyze a-tubulin
detyrosination.
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Figure 3. Enzymatic Characterization of CCP4 and CCP6
(A) Immunofluorescence of MEFs expressing either EGFP-CCP4 or EGFP-CCP6. Scale bar is 20 mm.
(B and C) Immunoblot of brain tubulin treated with protein extracts from HEK293 cells expressing (B) active or inactive EGFP-CCP4 and (C) active or inactive
EGFP-CCP6. Note the specific reduction of polyE signal after the treatment with active CCP4 or CCP6.
See also Figure S1 and Figure S4.CCP4 and CCP6 Also Generate D2-Tubulin
and Act as Long-Chain Deglutamylases
Our observation that in most of the organs of the pcd mice,
except skeletal muscles, D2-tubulin levels are comparable to
those in WT mice (Figure 2A) clearly showed that additional
enzyme(s) are involved in D2-tubulin generation. The CCP pro-
tein family, apart from CCP1, contains five additional members
(Kalinina et al., 2007; Rodriguez de la Vega et al., 2007). To
test whether any of the other CCPs generates D2-tubulin, we ex-
pressed them in MEFs. Immunofluorescence analysis with anti-
tyrosinated and anti-D2-tubulin antibodies demonstrated that in
addition to CCP1, CCP4 and CCP6 also generate D2-tubulin
(Figure 3A and Figure S4A). This result was confirmed by immu-
noblot analysis of HEK293 cells transfected with CCP4 and
CCP6 (Figures S4B and S4C). The level of tyrosinated tubulin
in cells expressing CCP4 and CCP6 remained unchanged, indi-
cating that these enzymes, similarly to CCP1, do not detyrosi-
nate tubulin (Figure 3A). We further tested whether CCP4 and
CCP6 also remove polyglutamylation. Using in vitro deglutamy-lation assays with brain tubulin and protein extracts from
HEK293 cells expressing either CCP4 or CCP6, we observed
a strong reduction in the polyE but not GT335 signal (Figures
3B and 3C). Finally, we tested whether CCP4 and CCP6 also re-
move glutamates from the primary sequence of MLCK1 and te-
lokin. After coexpressing MLCK or telokin with CCP4 or CCP6 in
HEK293 cells, both substrates were labeled with anti-D2-tubulin
but not polyE antibodies (Figures S4D and S4E). Thus CCP4 and
CCP6 generate D2-tubulin, catalyze shortening of glutamate
side chains, and remove all but one of the C-terminal glutamates
from MLCK1 and telokin, indicating that they are functional
homologs of CCP1.
Progressive Accumulation of Polyglutamylation
in the Cerebellum and Olfactory Bulb of the pcd Mice
Our immunoblot analysis of tubulin posttranslational modifica-
tions demonstrated that tubulin polyglutamylation is slightly
increased in the brain of adult pcd mice (Figure 2A). To test
whether this increase was confined to regions whereCell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc. 569
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Figure 4. Analysis of Tubulin Modifications in Different Brain Regions of the pcd Mice
(A) Immunoblot of protein extracts prepared from the cerebellum and cerebral cortex of WT and pcd mice at different stages of brain development (postnatal
days [P] 7, 14, and 21 and adult animals).
(B) Graphical representation of antibody signals detected in (A). The plotted values represent the relative intensities of the immunoblots of pcd samples
(WT = 100%) after normalization to total tubulin levels (12G10).
(C) Immunoblot of protein extracts from cerebellar granule neurons (CGNs) isolated at postnatal day 7 (P7) or cortical neurons isolated at embryonic day 17 (E17)
and cultured for 7 days (7DIV).
(D) Graphical representation of modification levels in pcd versus WT neurons. Relative intensities were calculated as in (B).
(E) Immunoblot of protein extracts from the olfactory bulbs of adult mice.
(F) Graphical representation of modification levels in pcd versus WT samples. Relative intensities were calculated as in (B).
See also Figure S5.neurodegeneration occurred, we analyzed the status of tubulin
modifications in the cerebellum, a part of the brain with exten-
sive degeneration, and in cerebral cortex where no degenera-
tion has been observed. Protein extracts from P7, P14, P21,
or adult WT and pcd mice were analyzed by immunoblot with
antibodies specific to tubulin modifications. At early develop-
mental stages, D2-tubulin levels were strongly reduced in
both the cerebellum and cortex of the pcd mice as compared
to WT (Figures 4A and 4B; lanes ‘‘P7’’; Figure S5A). At later
stages, D2-tubulin gradually increased reaching WT levels in
adult mice. However, the restoration of D2-tubulin modification
occurred earlier in the cortex as compared to the cerebellum
(Figures 4A and 4B).
Consistent with the deglutamylation activity of CCP1, the
degree of tubulin polyglutamylation was strongly increased in
the cortex and cerebellum of young pcd mice (Figures 4A and
4B; lanes ‘‘P7’’; Figure S5A). At later stages of development,570 Cell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc.polyglutamylation in the cortex was progressively reduced to
WT levels, whereas it continued to increase in the cerebellum
of the pcd mice. Moreover, the tubulin from the cerebellum of
adult pcdmice migrated slightly slower on the protein gel, which
emphasizes the strong accumulation of long polyglutamate
chains on tubulin (Figures 4A and 4B; lanes ‘‘adult’’). An unre-
lated tubulin modification, acetylation, was not significantly
affected in pcd mice at all developmental stages (Figures 4A
and 4B). This shows that not all tubulin modifications are
changed in the pcd mice, and that the changes observed for
D2-tubulin and polyglutamylation are likely to be a direct result
of the lack of CCP1 deglutamylating activity.
It was striking that polyglutamylation, which is strongly
increased in both the cerebellum and the cortex of the pcd
mice at earlier developmental stages, returns to WT levels in
adult mice only in the cortex but not in the cerebellum (Figures
4A and 4B). This implies the existence of a compensation
mechanism that would operate in the cortex but would be ineffi-
cient in the cerebellum. A compensating mechanism for CCP1 is
likely to involve enzymes with similar reaction specificities, such
as CCP4 and CCP6. In situ hybridization studies have previously
shown that CCP1 is highly expressed in the cerebellum and
cortex of adult mouse brain, whereas CCP6 expression was
rather restricted to the cortex, and CCP4 appeared to be gener-
ally expressed at low levels (Kalinina et al., 2007). We compared
the expression levels of CCP1, CCP4, and CCP6 in the cortex
and cerebellum at different developmental stages by reverse
transcription polymerase chain reaction (Figure S5B). Whereas
CCP1 appeared to be expressed at similar levels in both the
cerebellum and the cortex throughout all developmental stages,
CCP6 expression was very low in cerebellum as compared to
cortex. CCP4 expression was generally much lower in compar-
ison to CCP1 and CCP6 (visible only after 35 PCR cycles versus
25 cycles for CCP1 and CCP6; Figure S5B). Thus, it is possible
that CCP6 compensates for the absence of CCP1 in the cortex
of the pcdmice, whereas it is present at too low levels to achieve
a complete compensation in the cerebellum. As a consequence,
unopposed polyglutamylase activity results in tubulin hyperglu-
tamylation in the cerebellum. Strikingly, D2-tubulin generation,
which is also catalyzed by CCP1, is compensated in the cere-
bellum of the pcd mice, although less efficiently than in the
cortex (Figures 4A and 4B). This might be best explained by
the fact thatD2-tubulin generation is irreversible (Paturle-Lafane-
chere et al., 1991), thus allowing for progressive accumulation of
this modification.
To test whether the observed changes in tubulin modifications
are directly related to neurons, we analyzed different types of
neuronal cell cultures prepared from pcd and WT mice by
immunoblot. Cerebellar granule neurons (CGNs) isolated from
pcdmice at P7 and cultured for 7 days showed increased levels
of polyglutamylation and decreased D2-tubulin as compared to
CGNs isolated from WT mice, whereas tubulin acetylation was
unchanged. Similar results were obtained for primary cultures
of cortical neurons isolated fromWT and pcdmice at embryonic
day (E) 17 and cultured for 7 days (Figures 4C and 4D). Since
both neuronal cultures contained only very low amounts of glia
cells, these findings strongly suggest that the changes in tubulin
modifications observed in the extracts of the cerebellum and
cortex of pcd mice are related to neurons.
The correlation between tubulin hyperglutamylation and
neurodegeneration in thecerebellumofadultpcdmicesuggested
that degeneration of other regions of the brain in thesemicemight
also be related to increased tubulin polyglutamylation. To test this
hypothesis, we analyzed the status of tubulin modifications in the
olfactory bulbs, known to undergo neurodegeneration in adult
pcd mice. Similarly to cerebellum, we observed strong increase
in the levels of tubulin polyglutamylation, whereas acetylation
and D2-tubulin levels were unchanged (Figures 4E and 4F).
Thus, our results suggested that neurodegeneration observed in
the pcdmice is related to hyperglutamylation.
Purkinje Cell Degeneration in pcd Mice Is Caused
by Tubulin Hyperglutamylation
To unambiguously demonstrate the causal link between hyper-
glutamylation of tubulin observed in the pcd mice and neurode-generation, we aimed to rescue the Purkinje cell degeneration by
reducing the polyglutamylation levels in these neurons. Based on
the observation that most of the tubulin polyglutamylase activity
in brain is associated with the TTLL1-polyglutamylase complex
(Janke et al., 2005), we used shRNA that specifically depletes
TTLL1 to reduce polyglutamylation levels (Figure S6). Lentivirus
expressing TTLL1-specific shRNA (shTTLL1) and GFP or control
virus expressing only GFP were injected in the cerebellum of
10-day-old (postnatal day [P] 10) WT or pcd mice. The mice
were analyzed 30 days after injection (P40) by behavioral tests
and immunohistochemistry.
Analysis of cerebella from WT mice injected with control virus
(n = 6) showed that the differentiation of the Purkinje cell layer
was not affected by the virus injections, and that some of the
fully developed Purkinje cells expressed GFP, indicating that
these cells were infected by the virus (Figures 5A and 5B,
panels ‘‘WT + control virus’’). Cerebella from pcd mice injected
with control virus (n = 5) showed a complete degeneration of
the Purkinje cell layer 30 days post-injection, which is in accor-
dance with the expected degeneration of pcd mice cerebella at
this age (Figure 5A, panels ‘‘pcd + control virus’’). In contrast,
pcd mice cerebella injected with shTTLL1 virus (n = 6) dis-
played a large number of morphologically normal Purkinje cells
in the injected (GFP-positive) regions of the brain, which was
not the case in noninjected areas (Figures 5A and 5B, panels
‘‘pcd + virus shTTLL1’’). The rescue of Purkinje cell degenera-
tion by the downregulation of TTLL1 polyglutamylase demon-
strates that unopposed posttranslational polyglutamylation is
the primary cause of the neuronal degeneration in the pcd
mice.
To determine whether mice injected with shTTLL1 virus have
improved their motor coordination, we performed rotarod tests.
Under our experimental conditions, pcd mice injected with
control virus fell off the rod after 12 s whereas pcd mice in-
jected with shTTLL1 virus remained on the rod for 22 s (Fig-
ure 5C). Thus, injection of shTTLL1 virus in the cerebellum of
pcdmice led to a significant improvement of themotor coordina-
tion of these mice.
CCP5 Is a Protein Deglutamylase that Specifically
Removes the Branching Point Glutamates
Based on the analysis of CCP1, CCP4, and CCP6, it became
obvious that none of these enzymes catalyzed the removal of
branching point glutamates generated by TTLL4, or the ones
present on mouse brain MTs. To identify the enzyme(s) respon-
sible for the removal of these branching points, we screened
the remaining CCP family members for such activity by coex-
pressing themwith TTLL4. Using immunofluorescence, we iden-
tified CCP5 as the only enzyme that was able to remove TTLL4-
dependent monoglutamylation in U2OS cells. This process was
activity dependent, as an inactive version of CCP5 did not
prevent TTLL4-mediated glutamylation of MTs (Figure 6A). To
further characterize the specificity of CCP5, we used immuno-
blots with GT335 and polyE antibodies to compare the glutamy-
lation levels in HEK293 cells coexpressing CCP5 with either
TTLL4 or TTLL6. Whereas coexpression of TTLL4 with inactive
CCP5 inducedmonoglutamylation on several proteins, including
a- and b-tubulin, the coexpression with active CCP5 completelyCell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc. 571
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blocked the modification of the TTLL4 substrates (Figure 6B).
This suggested that CCP5 removes glutamylation not only from
tubulin but also from other substrates that were monoglutamy-
lated by TTLL4. In the case of TTLL6, expression with inactive
CCP5 resulted in generation of GT335 and polyE signals on tubu-
lins and TTLL6 itself, whereas expression with active CCP5
completely removed monoglutamylation and strongly reduced
polyglutamylation of tubulin. In addition, active CCP5 induced
a slight reduction of the GT335 labeling of the TTLL6 protein
band whereas the polyE signal remained unchanged, indicating
that only short side chains are removed (Figure 6B). Taken
together, these results clearly show that CCP5 removes branch-
ing point glutamates regardless of whether they were generated
by TTLL4 or TTLL6.
To determine whether the reduction in polyE signal after
coexpressing TTLL6 with CCP5 is related to a long chain deglu-
tamylase activity of CCP5, or if it was indirectly caused by the
removal of short side chains prior to elongation, we tested
CCP5 in an in vitro deglutamylation assay with brain tubulin.
Brain MTs are known to carry mostly long glutamate chains on
a-tubulin, whereas side chains on b-tubulin are predominantly
short (Redeker et al., 2004). When brain tubulin was incubated
with active CCP5, we observed complete removal of GT335
signal from b-tubulin but only a slight reduction of the signal on
a-tubulin. In contrast, no changes in the polyE signal were
observed (Figure 6C). These results strongly suggest that
CCP5 activity is restricted to the removal of branching point
glutamates, and that the enzyme does not shorten or remove
long glutamate chains. To confirm this hypothesis, we performed
additional in vitro assays using tubulin purified from HeLa cells
overexpressing TTLL4 (tubulin with short glutamate chains) or
TTLL6 (tubulin with long glutamate chains). Although CCP5
completely removed GT335 signal from TTLL4-modifed tubulin,
it only slightly reduced the GT335 labeling on TTLL6-modified
tubulin and did not affect the polyE labeling. Together with the
observation that CCP5 does not generate D2-tubulin (not
shown), these data are in agreement with CCP5 being a degluta-
mylase that specifically removes branching point glutamates
(Figure 6C).
Cooperative Mechanism of Tubulin Deglutamylation
To test whether the enzymes associated with each step of the
deglutamylation reaction could cooperate in the complete
elimination of polyglutamate chains, we performed an in vitro
deglutamylation assay in which we combined enzymes thatFigure 5. Rescue of Purkinje Cell Degeneration by TTLL1 Depletion
(A) Immunohistochemistry of thin cerebellar sections of WT or pcdmice injected
Purkinje cells are visualized with anti-calbindin D antibody, and the GFP signal w
cerebella, only the left-hand sides of the lobes were infected by the virus (GFP
shTTLL1-infected pcd brains, Purkinje cells survive. Note that GFP expression in
bar is 100 mm.
(B) Morphology of Purkinje cells from cerebella treated as in (A). Purkinje cells from
tree. Note that only few Purkinje cells are infected (GFP-positive). In pcd mice,
fected’’). In contrast, pcd Purkinje cells infected with shTTLL1 virus survived and
(C) Rotarod behavioral test of control and shTTLL1 virus-injected pcdmice at P40
75th percentiles boxes and whiskers corresponding to the minimal and maximal v
cylinder than control-injected mice (*p < 0.05; Mann and Whitney, nonparametric
See also Figure S6.shorten long glutamate chains (CCP1, CCP4, and CCP6) with
CCP5 that removes branching point glutamates. As a control
we also treated brain tubulin with each of the enzymes sepa-
rately. In agreement with our previous observations, CCP1,
CCP4, and CCP6 strongly reduced poly- but not monoglutamy-
lation on brain tubulin, whereas CCP5 treatment resulted in
a slight reduction of mono- but not polyglutamylation. However,
when we treated brain tubulin with a mixture of CCP5 and either
CCP1, CCP4, or CCP6, the polyglutamylation was completely
eliminated and monoglutamylation was decreased to almost
undetectable levels (Figure 6D). These results clearly show that
the two types of deglutamylating enzymes act in a cooperative
manner and that tubulin polyglutamylation is a completely
reversible posttranslational modification.DISCUSSION
A Family of Enzymes Catalyzing the Removal
of Posttranslational Polyglutamylation
Since the discovery that polyglutamylation is a strictly regulated
posttranslational modification (Audebert et al., 1993), the identi-
fication of the enzymes involved in generation and removal of the
glutamate side chains was considered as the key step toward
systematic functional studies. Whereas the glutamylating
enzymes have been identified (Janke et al., 2005; van Dijk
et al., 2007), the reverse enzymes have remained unknown until
the very recent description of a first mammalian deglutamylase,
CCP5 (Kimura et al., 2010). Here we provide evidence that in
mammals, besides CCP5, three additional members of the
CCP family (CCP1, CCP4, and CCP6) catalyze protein degluta-
mylation. We further show that the CCP deglutamylases differ
in their enzymatic specificities. On highly polyglutamylated brain
tubulin, CCP1, CCP4, and CCP6 catalyze the shortening of the
glutamate side chains, while CCP5 exclusively removes the
branching point glutamates (schematic representation: Figure 7).
A mechanism in which two types of enzymes cooperate to
completely remove polyglutamylation on brain MTs is in agree-
ment with the previous observation that deglutamylation in
neurons occurs at two different rates: a fast rate for shortening
of long glutamate side chains and a slower rate for the removal
of branching point glutamates (Audebert et al., 1993). This differ-
ential deglutamylation might allow for a tight control over the
distribution of mono- and polyglutamylation on MTs within cells
or even along single MTs.with lentivirus expressing either GFP (control) or GFP and shTTLL1 (Figure S6).
as amplified using an anti-GFP antibody. In the panels that represent the pcd
). In control-injected pcd brains, Purkinje cells are mostly absent, whereas in
Purkinje cells is clearly visible only at higher magnification (see panel B). Scale
WT brains infected with control virus show a typical highly complex dendritic
Purkinje cells survive rarely and show abnormal morphology (panel ‘‘non-in-
showed normal morphology. Scale bar is 20 mm.
(30 days after virus injection). The graphics represent median values with 25th–
alues. shTTLL1-injected pcdmice remained significantly longer on the rotating
t test, n = 4).
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Figure 6. Enzymatic Characterization of CCP5
and the Two-Step Deglutamylation Mechanism
(A) Immunofluorescence of U2OS cells coexpressing
TTLL4-EYFP and either active or inactive CCP5-
ECFP. The TTLL4-dependent GT335 labeling of MTs
is completely blocked by coexpression with active
CCP5.
(B) Immunoblot of protein extracts from HEK293 cells
coexpressing TTLL4-EYFP or TTLL6-EYFP with active
or inactive CCP5-EYFP. No GT335 signal is detected
after coexpression of active CCP5 and TTLL4. The
GT335 and the polyE signal are strongly diminished
on tubulin after coexpression of TTLL6 and active
CCP5, whereas the polyE signal on TTLL6 remains
unchanged.
(C) Immunoblot of tubulin treated with HEK293 cell
extracts after expression of either active or inactive
EYFP-CCP5. Three types of tubulin were used: brain
tubulin and HeLa tubulin modified with TTLL4 or
TTLL6. TTLL4-modified tubulin is not labeled with
polyE (not shown).
(D) Immunoblot of brain tubulin treated with cell
extracts containing each of the four CCPs or combina-
tions of CCP5-EYFP with EYFP-CCP1, EGFP-CCP4,
or EGFP-CCP6. Combinations of CCP5 and side-
chain shortening enzymes leads to the removal of
both polyE and GT335 signal from brain tubulin.
(*degradation product of EYFP-CCP1.)
See also Figure S1.
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Figure 7. The Enzymatic Mechanism of Protein Deglutamylation
Schematic representation of the deglutamylation reactions catalyzed by CCP1, CCP4, CCP5, and CCP6 on brain tubulin (A) and MLCK (B; the C-terminal
sequences of murine a1-tubulin and MLCK1 are represented). (A) CCP1, CCP4, and CCP6 shorten the long glutamate chains generated by posttranslational
polyglutamylation, and subsequently, CCP5 removes the branching point glutamate. They also catalyze the formation of D2-tubulin, which requires prior detyr-
osination. (B) The C-terminal stretch of glutamate residues of MLCK1 is shortened to one glutamate by CCP1, CCP4, or CCP6. (A and B) The epitopes recognized
by modification-specific antibodies are indicated (italic).Whereas polyglutamylation on brain MTs is mainly generated
by the TTLL1 polyglutamylase (Janke et al., 2005), other TTLLs
are responsible for polyglutamylation of other MT types. For
example, TTLL6 generates long side chains on axonemal MTs
and plays an essential role in ciliary functions (Pathak et al.,
2007; Suryavanshi et al., 2010; van Dijk et al., 2007). Strikingly,
we found that CCP1 catalyzes complete removal of glutamate
side chains including the branching point glutamates from MTs
modified by TTLL6. As TTLL1 and TTLL6 both preferentially
modify a-tubulin (Janke et al., 2005; van Dijk et al., 2007), this
suggests that TTLL6 might utilize sites on a-tubulin that are
more accessible to CCP1 than the sites modified by TTLL1.
Thus, the use of different modification sites could be an addi-
tional parameter that regulates the dynamics of polyglutamyla-
tion and contributes to the diversity of signals generated by
this modification.
CCPs Also Catalyze Primary Sequence Deglutamylation
Apart from posttranslationally added glutamates, CCP1, CCP4,
and CCP6 also remove gene-encoded glutamates from the Ctermini of proteins. We have shown that these enzymes catalyze
the removal of the C-terminal glutamate from detyrosinated
tubulin, which gives rise to D2-tubulin. This form of tubulin has
previously been identified as a fraction of tubulin that cannot be
re-tyrosinated by TTL and that accumulates on stableMTassem-
blies such as neuronal MTs (Paturle-Lafanechere et al., 1994). In
addition, we demonstrate that CCP1, CCP4, and CCP6 shorten
the C-terminal glutamate stretch of two important regulators of
myosin functions, MLCK and telokin (Gao et al., 2001; Herring
et al., 2006). Out of the eight gene-encoded glutamic acids
present at the veryC termini of theseproteins, seven are removed
(Figure 7). This is in agreement with previous studies, which have
revealed that telokin isolated from chicken gizzard has a variable
number of glutamates at its C terminus (Rusconi et al., 1997).
Our observation that additional, not yet identified proteins
undergo primary sequence deglutamylation suggests that this
modification might be a general feature of proteins with multiple
glutamate residues at their C termini. Understanding the func-
tional importance of C-terminal protein deglutamylation opens
an exciting new field for future research.Cell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc. 575
Polyglutamylation Is Linked to Neurodegeneration
Purkinje cell degeneration (pcd) micewere first described in 1976
(Mullen et al., 1976) and have since provided an excellent model
to study neurodegeneration. Since the discovery that these mice
lack functional CCP1 (also known as Nna1; Fernandez-Gonzalez
et al., 2002), several mechanisms explaining the neurodegenera-
tive phenotype of these mice have been proposed including lack
of tubulin detyrosination, decreased protein turnover, and mito-
chondrial defects (Berezniuk et al., 2010; Chakrabarti et al.,
2010; Kalinina et al., 2007). Based on our discovery that CCP1
is a protein deglutamylase, we have demonstrated that pcd
mice have increased levels of tubulin polyglutamylation specifi-
cally in the parts of the brain that undergo neurodegeneration,
such as the cerebellum and olfactory bulb. This suggested that
tubulin hyperglutamylation could be the cause of neurodegener-
ation in the pcdmice, and indeed, downregulation of the tubulin-
specific neuronal polyglutamylase (TTLL1) in the cerebellum of
young pcd mice prevented Purkinje cell death and improved
motor coordination. These experiments now unambiguously
demonstrate that tubulin hyperglutamylation is responsible for
the Purkinje cell degeneration in the pcdmice.
Tubulin polyglutamylation has been proposed to regulate
a number of MT functions. Recent studies have shown that poly-
glutamylation regulates MT-dynein interactions (Kubo et al.,
2010; Suryavanshi et al., 2010) as well as spastin-mediated MT
severing (Lacroix et al., 2010). Thus, it appears that tubulin
hyperglutamylation could affect the interactions of MAPs and
motors with the MT cytoskeleton and as a consequence lead
to neurodegeneration.Conclusion
Here we demonstrate that unlike previously suggested, CCP1 is
not the long-searched-for tubulin-detyrosinating enzyme but is
involved in the removal of glutamates from tubulin as well as
from other substrates. By analyzing additional members of the
CCP family, we have identified a group of tubulin-modifying
enzymes that generate D2-tubulin and that remove posttransla-
tionally added polyglutamylation. We have also shown that the
C-terminal deglutamylation of proteins is likely to be a general
posttranslational modification, which might have many yet
undiscovered roles in the regulation of protein functions. In addi-
tion, we found that loss of function of one of the deglutamylases
in the pcd mice leads to MT hyperglutamylation specifically in
brain regions that undergo neuronal degeneration. By depleting
the tubulin-specific neuronal polyglutamylase TTLL1, we were
able to prevent this degeneration, thus demonstrating that MT
hyperglutamylation is the primary cause of neurodegeneration
in the pcdmice. Taken together, we have characterized a family
of deglutamylating enzymes and, by analyzing the in vivo func-
tion of one of these deglutamylases, provided evidence that
the fine-tuning of the length of polyglutamate side chains on
MTs is critical for neuronal function and survival.EXPERIMENTAL PROCEDURES
Characterization of CCPs
MLCK, telokin, and CCP cDNA sequences from the NCBI database or predicted
for CCP4 and CCP6 were cloned into various expression plasmids after amplifi-576 Cell 143, 564–578, November 12, 2010 ª2010 Elsevier Inc.cation frommurinecDNA. Enzymatically inactiveCCPswere generatedbymuta-
genizing a conserved zinc-binding motif (Figure S1). CCPs fused to fluorescent
proteins were expressed in cultured cells. GST-tagged MLCK and telokin were
expressed inbacteria, 6His-taggedCCP1 in thebaculovirus-infected insectcells,
and proteins were purified by affinity. Pig brain tubulin was purified as described
before (Vallee, 1986). Glutamylated tubulin was purified from HeLa cells 24 hr
after transfection with either TTLL4 or TTLL6 by affinity on a GT335-column as
previously described (van Dijk et al., 2008). Enzymatic activitieswere determined
by incubating the extracts of CCP-expressing HEK293 cells with brain tubulin,
tubulin fromHeLa cells, or purifiedMLCKor telokin at 37C for 6 hr and analyzing
them by SDS-PAGE and immunoblot. For immunoprecipitation, tissue extracts
were incubated with protein G-coupled magnetic beads coated with anti-
MLCK1 antibody, and bound proteins were analyzed by immunoblot.
Mouse Experiments
Mouse experiments were performed in accordance with institutional and
national regulations and have been approved by the local ethics committee.
Pcd mice (BALB/cByJ-Agtpbp1pcd-3J-J) were obtained from The Jackson
Laboratories. For tissue preparation or cell culture, mice were sacrificed and
organs were quickly dissected. Control or TTLL1-specific shRNA in lentivirus
was injected into the left hemisphere of the cerebellum of anesthetized P10
mouse pups using a micro-pump. Mice were analyzed 30 days after injection
(P40) using behavioral tests or immunohistochemistry. Sensorimotor coordi-
nation was assayed on a rotarod. Mice were trained on the rotating cylinders
at constant speed (4 rpm) until they remained on the rod for 15 s, and the
latency to fall from the rod was determined by accelerating the rod every 8 s
by 1 rpm. Each mouse was assayed in six successive trials, and medians
were calculated and tested using the Mann andWhitney, nonparametric t test.
Cell Culture, Immunohistochemistry, and Immunoblot
Cerebellar granule neuron cultureswere prepared from7-day-oldmurine pups,
cortical neuron cultures from E17.5 embryos, and MEFs from E13.5 embryos
following standard procedures. HEK293 and HeLa cell lines were grown under
standard conditions. Cells were either directly analyzed by SDS-PAGE or fixed
for immunohistochemistry using standard procedures. Brain sections were
permeabilized for 45 min in PBS containing 0.3% (v/v) Triton X-100 and
5% (v/v) normal goat serum (NGS), washed, and incubated overnight with
primary antibody. SDS-PAGE and immunoblot were performed using standard
protocols. Cells, brain sections, or membranes were incubated with rabbit
polyE, anti-GFP, anti-GST, anti-detyrosinated tubulin or anti-D2-tubulin anti-
bodies, mouse anti-calbindin D-28K, anti-MLCK1, GT335, 6-11B-1, and
12G10, or rat anti-tyrosinated tubulin (YL1/2) antibodies. For immunohisto-
chemistry, anti-mouse, anti-rabbit, or anti-rat antibodies conjugatedwith either
Alexa 555 or Alexa 488, Cy3 or Cy5 fluorophores were used and nuclei were
stained using either DAPI orHoechst 33258. Fluorescent imageswere acquired
with a LSM 710 confocal, Axioskop 50 (Carl Zeiss MicroImaging) or DMRA (Le-
ica) microscope and Metamorph software. Protein bands on immunoblots
were visualized with HRP-labeled donkey anti-rabbit, anti-mouse, or anti-rat
IgG followed by detection with chemiluminescence. For the graphical repre-
sentation of modification levels in Figure 4, protein bands from immunoblots
were quantified using ImageJ software.
ACCESSION NUMBERS
Sequences for CCP4 and CCP6 have been deposited in public databases with
the accession numbers FN429927 and FN427928.
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